“Revolutionizing Healthcare: TheraLaser Proves Effective in Treating Ongoing Conditions”
Theralase® Validates Previous University Research on RuvidarTM for Herpes Simplex Virus Treatment This press release from Theralase® Technologies Inc. highlights a significant breakthrough in the treatment of the Herpes Simplex Virus (HSV-1). The company has validated previous research conducted at the University of Manitoba, demonstrating that RuvidarTM is safe and effective in inactivating HSV-1 in…